Page last updated: 2024-11-03

propranolol and Adenohypophyseal Diseases

propranolol has been researched along with Adenohypophyseal Diseases in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brechignac, X1
Broussolle, C1
Nove-Josserand, R1
Vital-Durand, D1
Orgiazzi, J1
Levrat, R1
Itoh, M1
Itatsu, T1
Yamauchi, K1
Hara, I1
Nihei, N1

Other Studies

2 other studies available for propranolol and Adenohypophyseal Diseases

ArticleYear
[Hyperthyroidism at elevated thyreostimulin. A case with pituitary resistance to thyroid hormones].
    Presse medicale (Paris, France : 1983), 1994, Jun-18, Volume: 23, Issue:23

    Topics: Adult; Drug Therapy, Combination; Humans; Hyperthyroidism; Male; Pituitary Diseases; Propranolol; Re

1994
[Studies on the effects of simultaneous administrations of propranolol and glucagon on the release of growth hormone (author's transl)].
    Nihon Naibunpi Gakkai zasshi, 1977, Feb-20, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Arginine; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hor

1977